| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +16.9% |
| Cost of Revenue | $138K | -39.9% |
| Gross Profit | $995K | +34.5% |
| R&D Expense | $1.6M | +24.9% |
| SG&A Expense | $4.8M | -27.9% |
| Operating Income | -$8.1M | +24.2% |
| Pre-tax Income | -$8.4M | +23.3% |
| Net Income | -$8.4M | +23.3% |
| EPS (Basic) | -$0.41 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $61K | +224.5% |
| Inventory | $324K | -17.1% |
| Current Assets | $5.6M | +438.5% |
| Total Assets | $9.3M | +199.8% |
| Current Liabilities | $4.3M | +205.6% |
| Total Liabilities | $5.1M | +110.8% |
| Stockholders' Equity | $4.2M | +515.1% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | +28.3% |
| Capital Expenditures | $63K | -79.5% |
| Investing Cash Flow | -$563K | -82.3% |
| Financing Cash Flow | $6.0M | -17.9% |
| Free Cash Flow | -$5.4M | +30.3% |
| +47.4% |
| EPS (Diluted) | -$0.41 | +47.4% |